curaleaf holdings - CURLF

CURLF

Close Chg Chg %
2.44 0.22 9.02%

Closed Market

2.66

+0.22 (9.02%)

Volume: 521.69K

Last Updated:

Dec 4, 2025, 3:59 PM EDT

Company Overview: curaleaf holdings - CURLF

CURLF Key Data

Open

$2.49

Day Range

2.44 - 2.71

52 Week Range

0.68 - 3.65

Market Cap

$1.88B

Shares Outstanding

772.15M

Public Float

480.05M

Beta

0.91

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.35

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

484.99K

 

CURLF Performance

1 Week
 
16.56%
 
1 Month
 
-0.23%
 
3 Months
 
-6.67%
 
1 Year
 
55.56%
 
5 Years
 
-78.34%
 

CURLF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 9
Full Ratings ➔

About curaleaf holdings - CURLF

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

CURLF At a Glance

Curaleaf Holdings, Inc.
420 Lexington Avenue
New York, New York 10170
Phone N/A Revenue 1.34B
Industry Agricultural Commodities/Milling Net Income -238,169,000.00
Sector Process Industries Employees N/A
Fiscal Year-end 12 / 2025
View SEC Filings

CURLF Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.859
Price to Book Ratio 1.356
Price to Cash Flow Ratio 7.10
Enterprise Value to EBITDA 8.291
Enterprise Value to Sales 1.669
Total Debt to Enterprise Value 0.474

CURLF Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 20.198
Total Asset Turnover 0.444

CURLF Liquidity

Current Ratio 1.108
Quick Ratio 0.539
Cash Ratio 0.276

CURLF Profitability

Gross Margin 34.81
Operating Margin 1.504
Pretax Margin -8.76
Net Margin -17.737
Return on Assets -7.687
Return on Equity -24.31
Return on Total Capital -12.079
Return on Invested Capital -12.025

CURLF Capital Structure

Total Debt to Total Equity 123.398
Total Debt to Total Capital 55.237
Total Debt to Total Assets 36.03
Long-Term Debt to Equity 107.46
Long-Term Debt to Total Capital 48.102
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Curaleaf Holdings - CURLF

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
1.21B 1.34B 1.35B 1.34B
Sales Growth
+93.04% +10.47% +0.77% -0.28%
Cost of Goods Sold (COGS) incl D&A
1.08B 873.16M 868.97M 875.38M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
132.64M 176.47M 211.91M 250.16M
Depreciation
- - 90.83M 101.92M
-
Amortization of Intangibles
- - 121.08M 148.23M
-
COGS Growth
+104.66% -19.41% -0.48% +0.74%
Gross Income
126.19M 463.18M 477.67M 467.43M
Gross Income Growth
+29.79% +267.05% +3.13% -2.14%
Gross Profit Margin
+10.43% +34.66% +35.47% +34.81%
2021 2022 2023 2024 5-year trend
SG&A Expense
415.74M 475.56M 434.78M 447.23M
Research & Development
- - - -
-
Other SG&A
415.74M 475.56M 434.78M 447.23M
SGA Growth
+61.04% +14.39% -8.57% +2.86%
Other Operating Expense
- - - -
-
Unusual Expense
(450.61M) 144.26M 65.01M 53.99M
EBIT after Unusual Expense
161.06M (156.63M) (22.13M) (33.79M)
Non Operating Income/Expense
(6.00M) 23.53M (1.86M) 16.78M
Non-Operating Interest Income
629.00K 137.00K 23.00K 776.00K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
90.26M 93.33M 100.38M 100.62M
Interest Expense Growth
+30.81% +3.40% +7.56% +0.23%
Gross Interest Expense
90.26M 93.33M 100.38M 100.62M
Interest Capitalized
- - - -
-
Pretax Income
64.80M (226.43M) (124.37M) (117.63M)
Pretax Income Growth
+193.95% -449.45% +45.08% +5.42%
Pretax Margin
+5.36% -16.94% -9.24% -8.76%
Income Tax
173.93M 150.50M 114.59M 98.59M
Income Tax - Current - Domestic
154.82M 176.49M 143.90M 151.31M
Income Tax - Current - Foreign
- (304.00K) 123.00K 1.88M
Income Tax - Deferred - Domestic
19.11M (23.30M) (29.83M) (50.21M)
Income Tax - Deferred - Foreign
- (2.39M) 394.00K (4.39M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - (22.75M)
-
Consolidated Net Income
(109.13M) (376.93M) (238.96M) (238.97M)
Minority Interest Expense
(7.40M) (6.83M) (9.14M) (6.58M)
Net Income
(101.73M) (370.10M) (229.82M) (232.38M)
Net Income Growth
-64.79% -263.80% +37.90% -1.12%
Net Margin Growth
-8.41% -27.69% -17.07% -17.31%
Extraordinaries & Discontinued Operations
- - (51.38M) (5.79M)
-
Discontinued Operations
- - (51.38M) (5.79M)
-
Net Income After Extraordinaries
(101.73M) (370.10M) (281.20M) (238.17M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(101.73M) (370.10M) (281.20M) (238.17M)
EPS (Basic)
-0.1456 -0.5204 -0.3883 -0.3215
EPS (Basic) Growth
-31.41% -257.42% +25.38% +17.20%
Basic Shares Outstanding
698.76M 711.16M 724.12M 740.83M
EPS (Diluted)
-0.1456 -0.5204 -0.3883 -0.3215
EPS (Diluted) Growth
-31.41% -257.42% +25.38% +17.20%
Diluted Shares Outstanding
698.76M 711.16M 724.12M 740.83M
EBITDA
(156.90M) 164.10M 254.80M 270.35M
EBITDA Growth
-116.54% +204.59% +55.27% +6.10%
EBITDA Margin
-12.97% +12.28% +18.92% +20.13%

Snapshot

Average Recommendation BUY Average Target Price 3.695
Number of Ratings 9 Current Quarters Estimate -0.076
FY Report Date 12 / 2025 Current Year's Estimate -0.29
Last Quarter’s Earnings -0.066 Median PE on CY Estimate N/A
Year Ago Earnings -0.29 Next Fiscal Year Estimate -0.227
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 4 7 6
Mean Estimate -0.08 -0.07 -0.29 -0.23
High Estimates -0.07 -0.07 -0.24 -0.14
Low Estimate -0.09 -0.08 -0.32 -0.28
Coefficient of Variance -12.41 -8.08 -9.31 -25.81

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 7 6 6
OVERWEIGHT 2 2 1
HOLD 0 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Curaleaf Holdings in the News